Australia markets closed

ASLAN Pharmaceuticals Limited (ASLN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7700-0.0600 (-2.12%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.8300
Open2.8500
Bid0.0000 x 1400
Ask0.0000 x 1200
Day's range2.7300 - 2.8800
52-week range1.2600 - 6.7500
Volume121,213
Avg. volume891,511
Market cap192.573M
Beta (5Y monthly)2.41
PE ratio (TTM)N/A
EPS (TTM)-0.4750
Earnings date11 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.00
  • ASLAN Pharmaceuticals Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures
    GlobeNewswire

    ASLAN Pharmaceuticals Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures

    Funds extend expected cash runway through late 2023 and enable advancement of clinical program for ASLAN003SINGAPORE, July 13, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it has closed a secured loan facility provided by K2 HealthVentures (K2HV). Under the terms of the facility, K2HV will provide ASLAN up to $45 million of secur

  • Why ASLAN Pharmaceuticals Blasted Higher on Friday
    Motley Fool

    Why ASLAN Pharmaceuticals Blasted Higher on Friday

    Shareholders of ASLAN Pharmaceuticals (NASDAQ: ASLN) are primed for a good weekend. Raycroft believes the shares are worth $8 apiece, more than 150% higher than Thursday's closing price. ASLAN, a clinical-stage immunology biotech, only has two treatments in development.

  • New Strong Sell Stocks for June 8th
    Zacks

    New Strong Sell Stocks for June 8th

    ASLN, CANG, ESLT, GCI, and KRYS have been added to the Zacks Rank #5 (Strong Sell) List on June 8, 2021.